A project established to monitor prenatal exposures to antiretroviral (ARV) drugs and to detect any potential increase in the risk of related birth defects. Pregnant women exposed to ARV drugs voluntarily enroll in the Registry through their health care providers. Information provided to the Registry includes no identifying patient information.